More News
8 January 2013
Chugai and Debiopharm Group Announce an Exclusive License Agreement for Anti-Cancer Agent, FF284 (Debio 1347)7 January 2013
MacroGenics and Gilead Sciences Enter Strategic Alliance to Develop and Commercialize Four DART Products3 January 2013
Sutro Biopharma to Collaborate with Sanofi Pasteur on a Novel Production Approach for Vaccine Candidates3 January 2013
Microbiotix Announces Exclusive Worldwide Licensing Agreement for HCV NS5B Non-Nucleoside Polymerase Inhibitors3 January 2013
NGM Enters Agreement With Janssen to Discover and Develop Novel Therapeutics for Diabetes3 January 2013
Repligen Announces Licensing Agreement with Pfizer for Spinal Muscular Atrophy Program3 January 2013
Cellular Dynamics Announces Agreement with AstraZeneca on Use of iPSC-derived Human Cells in Drug Discovery ResearchNews Channels
Newsletter
La Merie Biologics
La Merie Publishing releases a weekly newsletter with a focus on biopharmaceutical research and development.
Subscribe
Newsletter
New Product Alert
La Merie Publishing offers an e-mail notification service about the release of new products of La Merie Publishing. This New Product Release Alert also informs about the release of FREE reports produced by La Merie Publishing.
Subscribe
Featured reports